Share-based Payment Arrangement, Expense of ULTRALIFE CORP from 31 Dec 2015 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
ULTRALIFE CORP quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2015 to 30 Sep 2025.
  • ULTRALIFE CORP Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $236,000, a 39% increase year-over-year.
  • ULTRALIFE CORP Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $906,000, a 53% increase year-over-year.
  • ULTRALIFE CORP annual Share-based Payment Arrangement, Expense for 2024 was $698,000, a 32% increase from 2023.
  • ULTRALIFE CORP annual Share-based Payment Arrangement, Expense for 2023 was $528,000, a 32% decline from 2022.
  • ULTRALIFE CORP annual Share-based Payment Arrangement, Expense for 2022 was $776,000, a 16% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

ULTRALIFE CORP Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $906,000 $236,000 +$66,000 +39% 01 Jul 2025 30 Sep 2025 10-Q 17 Nov 2025 2025 Q3
Q2 2025 $840,000 $235,000 +$76,000 +48% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $764,000 $227,000 +$66,000 +41% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $698,000 $208,000 +$104,000 +100% 01 Oct 2024 31 Dec 2024 10-K 01 Apr 2025 2024 FY
Q3 2024 $594,000 $170,000 +$39,000 +30% 01 Jul 2024 30 Sep 2024 10-Q 17 Nov 2025 2025 Q3
Q2 2024 $555,000 $159,000 +$5,000 +3.2% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 $550,000 $161,000 +$22,000 +16% 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025 2025 Q1
Q4 2023 $528,000 $104,000 -$120,000 -54% 01 Oct 2023 31 Dec 2023 10-K 01 Apr 2025 2024 FY
Q3 2023 $648,000 $131,000 -$48,000 -27% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $696,000 $154,000 -$30,000 -16% 01 Apr 2023 30 Jun 2023 10-Q 25 Jul 2024 2024 Q2
Q1 2023 $726,000 $139,000 -$50,000 -26% 01 Jan 2023 31 Mar 2023 10-Q 25 Apr 2024 2024 Q1
Q4 2022 $776,000 $224,000 +$67,000 +43% 01 Oct 2022 31 Dec 2022 10-K 21 Mar 2024 2023 FY
Q3 2022 $709,000 $179,000 +$37,000 +26% 01 Jul 2022 30 Sep 2022 10-Q 26 Oct 2023 2023 Q3
Q2 2022 $672,000 $184,000 -$2,000 -1.1% 01 Apr 2022 30 Jun 2022 10-Q 27 Jul 2023 2023 Q2
Q1 2022 $674,000 $189,000 +$3,000 +1.6% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q4 2021 $671,000 $157,000 -$30,000 -16% 01 Oct 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 $701,000 $142,000 -$80,000 -36% 01 Jul 2021 30 Sep 2021 10-Q 27 Oct 2022 2022 Q3
Q2 2021 $781,000 $186,000 -$118,000 -39% 01 Apr 2021 30 Jun 2021 10-Q 29 Jul 2021 2021 Q2
Q1 2021 $899,000 $186,000 -$44,000 -19% 01 Jan 2021 31 Mar 2021 10-Q 28 Jul 2022 2022 Q2
Q4 2020 $943,000 $187,000 -$47,000 -20% 01 Oct 2020 31 Dec 2020 10-K 08 Mar 2022 2021 FY
Q3 2020 $990,000 $222,000 +$63,000 +40% 01 Jul 2020 30 Sep 2020 10-Q 28 Oct 2021 2021 Q3
Q2 2020 $927,000 $304,000 +$129,000 +74% 01 Apr 2020 30 Jun 2020 10-Q 29 Jul 2021 2021 Q2
Q1 2020 $798,000 $230,000 +$45,000 +24% 01 Jan 2020 31 Mar 2020 10-Q 29 Apr 2021 2021 Q1
Q4 2019 $753,000 $234,000 +$51,000 +28% 30 Sep 2019 31 Dec 2019 10-K 04 Feb 2021 2020 FY
Q3 2019 $702,000 $159,000 -$204,000 -56% 01 Jul 2019 29 Sep 2019 10-Q 29 Oct 2020 2020 Q3
Q2 2019 $906,000 $175,000 -$30,000 -15% 01 Apr 2019 30 Jun 2019 10-Q 30 Jul 2020 2020 Q2
Q1 2019 $936,000 $185,000 +$46,000 +33% 01 Jan 2019 31 Mar 2019 10-Q 30 Apr 2020 2020 Q1
Q4 2018 $890,000 $183,000 +$59,000 +48% 01 Oct 2018 31 Dec 2018 10-K 06 Feb 2020 2019 FY
Q3 2018 $831,000 $363,000 +$230,000 +173% 02 Jul 2018 30 Sep 2018 10-Q 31 Oct 2019 2019 Q3
Q2 2018 $601,000 $205,000 -$151,000 -42% 01 Apr 2018 01 Jul 2018 10-Q 01 Aug 2019 2019 Q2
Q1 2018 $752,000 $139,000 +$99,000 +248% 01 Jan 2018 01 Apr 2018 10-Q 02 May 2019 2019 Q1
Q4 2017 $653,000 $124,000 -$31,000 -20% 02 Oct 2017 31 Dec 2017 10-K/A 15 Feb 2019 2018 FY
Q3 2017 $684,000 $133,000 -$72,000 -35% 03 Jul 2017 01 Oct 2017 10-Q 01 Nov 2018 2018 Q3
Q2 2017 $756,000 $356,000 +$187,000 +111% 03 Apr 2017 02 Jul 2017 10-Q 02 Aug 2018 2018 Q2
Q1 2017 $569,000 $40,000 -$141,000 -78% 01 Jan 2017 02 Apr 2017 10-Q 03 May 2018 2018 Q1
Q4 2016 $710,000 $155,000 26 Sep 2016 31 Dec 2016 10-K 08 Feb 2018 2017 FY
Q3 2016 $205,000 27 Jun 2016 25 Sep 2016 10-Q 02 Nov 2017 2017 Q3
Q2 2016 $169,000 28 Mar 2016 26 Jun 2016 10-Q 03 Aug 2017 2017 Q2
Q1 2016 $181,000 01 Jan 2016 27 Mar 2016 10-Q 04 May 2017 2017 Q1

ULTRALIFE CORP Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $698,000 +$170,000 +32% 01 Jan 2024 31 Dec 2024 10-K 01 Apr 2025 2024 FY
2023 $528,000 -$248,000 -32% 01 Jan 2023 31 Dec 2023 10-K 01 Apr 2025 2024 FY
2022 $776,000 +$105,000 +16% 01 Jan 2022 31 Dec 2022 10-K 21 Mar 2024 2023 FY
2021 $671,000 -$272,000 -29% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
2020 $943,000 +$190,000 +25% 01 Jan 2020 31 Dec 2020 10-K 08 Mar 2022 2021 FY
2019 $753,000 -$137,000 -15% 01 Jan 2019 31 Dec 2019 10-K 04 Feb 2021 2020 FY
2018 $890,000 +$237,000 +36% 01 Jan 2018 31 Dec 2018 10-K 06 Feb 2020 2019 FY
2017 $653,000 -$57,000 -8% 01 Jan 2017 31 Dec 2017 10-K/A 15 Feb 2019 2018 FY
2016 $710,000 +$139,000 +24% 01 Jan 2016 31 Dec 2016 10-K 08 Feb 2018 2017 FY
2015 $571,000 01 Jan 2015 31 Dec 2015 10-K 09 Feb 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.